Suven Life Sciences to Present Three Posters on Samelisant at SLEEP-2026 Annual Meeting
Hyderabad, India (June 12, 2026) - Suven Life Sciences Limited, a clinical-stage biopharmaceutical company specializing in CNS disorder treatments, announced that it will present three posters detailing the clinical advancement of Samelisant (SUVN-G3031) at the SLEEP-2026 Annual Meeting. The event is hosted by the Associated Professional Sleep Societies (APSS), LLC and will take place in Baltimore, USA, from June 14-17, 2026.The APSS meeting, which is a joint venture of the American Academy of Sleep Medicine and the Sleep Research Society, serves as a premier scientific forum focusing on sleep medicine, circadian research, and sleep health. SLEEP...